Sarepta Therapeutics | SRPT - Текущие обязательства





Текущие обязательства Изменить Дата
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 23.23B 2.27B 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Capricor Therapeutics USD 29.9M 3.07M 2026-09
Daiichi Sankyo JPY 882.78B 117.08B 2026-09
Eli Lilly USD 47B 745M 2026-09
Gilead Sciences USD 12B 982M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Insmed USD 596.57M 157.83M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
Moderna USD 2.03B 506M 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novavax USD 329.84M 729K 2026-09
Pfizer USD 31.73B 920M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 29.77B 2.16B 2026-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Tectonic Therapeutic USD 10.37M 2.59M 2026-06
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09